Hollsteen
← Uber

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2016: −$4.6B · 10-K 0001543151-20-000010 filed Mar 2, 2020Equity incl. NCI · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2017: −$8.6B · 10-K 0001543151-20-000010 filed Mar 2, 2020Equity incl. NCI · Q1 2018: −$4.7B · 10-Q 0001628280-19-007524 filed Jun 4, 2019Equity incl. NCI · Q2 2018: −$5.5B · 10-Q 0001543151-19-000009 filed Aug 9, 2019Equity incl. NCI · Q3 2018: −$6.5B · 10-Q 0001543151-19-000017 filed Nov 5, 2019Equity incl. NCI · Q4 2018: −$7.4B · 10-K 0001543151-20-000010 filed Mar 2, 2020Equity incl. NCI · Q1 2019: −$8.4B · 10-Q 0001628280-19-007524 filed Jun 4, 2019Equity incl. NCI · Q2 2019: $15.9B · 10-Q 0001543151-19-000009 filed Aug 9, 2019Equity incl. NCI · Q3 2019: $15.7B · 10-Q 0001543151-19-000017 filed Nov 5, 2019Equity incl. NCI · Q4 2019: $14.9B · 10-K 0001543151-20-000010 filed Mar 2, 2020Equity incl. NCI · Q1 2020: $12.0B · 10-Q 0001543151-20-000022 filed May 8, 2020Equity incl. NCI · Q2 2020: $10.2B · 10-Q 0001543151-20-000029 filed Aug 7, 2020Equity incl. NCI · Q3 2020: $9.6B · 10-Q 0001628280-20-015936 filed Nov 6, 2020Equity incl. NCI · Q4 2020: $13.0B · 10-K 0001543151-21-000014 filed Mar 1, 2021Equity incl. NCI · Q1 2021: $13.6B · 10-Q 0001543151-21-000029 filed May 6, 2021Equity incl. NCI · Q2 2021: $14.2B · 10-Q 0001543151-21-000038 filed Aug 5, 2021Equity incl. NCI · Q3 2021: $14.1B · 10-Q 0001543151-21-000047 filed Nov 9, 2021Equity incl. NCI · Q4 2021: $15.1B · 10-K 0001543151-22-000008 filed Feb 24, 2022Equity incl. NCI · Q1 2022: $9.6B · 10-Q 0001543151-22-000015 filed May 5, 2022Equity incl. NCI · Q2 2022: $7.4B · 10-Q 0001543151-22-000024 filed Aug 4, 2022Equity incl. NCI · Q3 2022: $7.0B · 10-Q 0001543151-22-000034 filed Nov 2, 2022Equity incl. NCI · Q4 2022: $8.1B · 10-K 0001543151-23-000010 filed Feb 21, 2023Equity incl. NCI · Q1 2023: $8.3B · 10-Q 0001543151-23-000016 filed May 3, 2023Equity incl. NCI · Q2 2023: $9.4B · 10-Q 0001543151-23-000025 filed Aug 2, 2023Equity incl. NCI · Q3 2023: $10.1B · 10-Q 0001543151-23-000039 filed Nov 7, 2023Equity incl. NCI · Q4 2023: $12.0B · 10-K 0001543151-24-000012 filed Feb 15, 2024Equity incl. NCI · Q1 2024: $11.8B · 10-Q 0001543151-24-000020 filed May 8, 2024Equity incl. NCI · Q2 2024: $13.2B · 10-Q 0001543151-24-000027 filed Aug 6, 2024Equity incl. NCI · Q3 2024: $15.6B · 10-Q 0001543151-24-000036 filed Oct 31, 2024Equity incl. NCI · Q4 2024: $22.4B · 10-K 0001543151-25-000008 filed Feb 14, 2025Equity incl. NCI · Q1 2025: $22.8B · 10-Q 0001543151-25-000015 filed May 7, 2025Equity incl. NCI · Q2 2025: $23.4B · 10-Q 0001543151-25-000023 filed Aug 6, 2025Equity incl. NCI · Q3 2025: $29.0B · 10-Q 0001543151-25-000033 filed Nov 4, 2025Equity incl. NCI · Q4 2025: $27.9B · 10-K 0001543151-26-000015 filed Feb 13, 2026Equity incl. NCI · Q1 2026: $25.6B · 10-Q 0001543151-26-000022 filed May 6, 2026Equity incl. NCI · Q2 2026: $28.2B · 10-Q 0001543151-26-000032 filed Aug 5, 202612.028.2−4.629.0Q1 2016Q2 2026Q4 2023
$BEquity incl. NCI · Q4 2022: $8.1B · 10-K 0001543151-23-000010 filed Feb 21, 2023Equity incl. NCI · Q1 2023: $8.3B · 10-Q 0001543151-23-000016 filed May 3, 2023Equity incl. NCI · Q2 2023: $9.4B · 10-Q 0001543151-23-000025 filed Aug 2, 2023Equity incl. NCI · Q3 2023: $10.1B · 10-Q 0001543151-23-000039 filed Nov 7, 2023Equity incl. NCI · Q4 2023: $12.0B · 10-K 0001543151-24-000012 filed Feb 15, 2024Equity incl. NCI · Q1 2024: $11.8B · 10-Q 0001543151-24-000020 filed May 8, 2024Equity incl. NCI · Q2 2024: $13.2B · 10-Q 0001543151-24-000027 filed Aug 6, 2024Equity incl. NCI · Q3 2024: $15.6B · 10-Q 0001543151-24-000036 filed Oct 31, 202412.015.68.1Q4 2022Q3 2024Q4 2023
Q4 2023
12.0$B
All values (36)
PeriodValue ($B)Status
Q2 202628.2reported
Q1 202625.6reported
Q4 202527.9reported
Q3 202529.0reported
Q2 202523.4reported
Q1 202522.8reported
Q4 202422.4reported
Q3 202415.6reported
Q2 202413.2reported
Q1 202411.8reported
Q4 202312.0reported
Q3 202310.1reported
Q2 20239.4reported
Q1 20238.3reported
Q4 20228.1reported
Q3 20227.0reported
Q2 20227.4reported
Q1 20229.6reported
Q4 202115.1reported
Q3 202114.1reported
Q2 202114.2reported
Q1 202113.6reported
Q4 202013.0reported
Q3 20209.6reported
Q2 202010.2reported
Q1 202012.0reported
Q4 201914.9reported
Q3 201915.7reported
Q2 201915.9reported
Q1 2019−8.4reported
Q4 2018−7.4reported
Q3 2018−6.5reported
Q2 2018−5.5reported
Q1 2018−4.7reported
Q4 2017−8.6reported
Q1 2017 – Q3 2017–missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods.
Q4 2016Noneerror
Q1 2016 – Q3 2016–missing (3 periods): Grund wie bei Q1 2017 – Q3 2017.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Uber

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$12.0B
Period
Q4 2023, ended Dec 31, 2023 · as of Dec 31, 2023 (balance as of date, not a sum)
Source
10-K, filed Feb 15, 2024 · 0001543151-24-000012
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$12.0BFeb 15, 202410-K 0001543151-24-000012reported · confidence 1. · current